Literature DB >> 25842068

Guidelines on the diagnosis and treatment of primary liver cancer (2011 edition).

Shukui Qin1.   

Abstract

Entities:  

Year:  2012        PMID： 25842068     DOI： 10.3978/j.issn.2304-3865.2012.07.01

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN： 2304-3865


× No keyword cloud information.
  27 in total

1.  Clinical significance of microRNA-155 expression in hepatocellular carcinoma.

Authors:  Chengnong Guan; Feng Yang; Xichun He; Tuhua Li; Qingmei Yang; Huiping He; Meng Xu
Journal:  Oncol Lett       Date:  2015-12-22       Impact factor: 2.967

Review 2.  Interpretation of guidelines for the diagnosis and treatment of primary liver cancer (2019 edition) in China.

Authors:  Guoteng Qiu; Zhaoxing Jin; Xin Chen; Jiwei Huang
Journal:  Glob Health Med       Date:  2020-10-31

3.  miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression.

Authors:  Wenjing Mu; Chaobo Hu; Haibin Zhang; Zengqiang Qu; Jin Cen; Zhixin Qiu; Chao Li; Haozhen Ren; Yixue Li; Xianghuo He; Xiaolei Shi; Lijian Hui
Journal:  Cell Res       Date:  2015-02-20       Impact factor: 25.617

4.  Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition).

Authors:  Juxian Sun; Rongping Guo; Xinyu Bi; Mengchao Wu; Zhaoyou Tang; Wan Yee Lau; Shusen Zheng; Xuehao Wang; Jinming Yu; Xiaoping Chen; Jia Fan; Jiahong Dong; Yongjun Chen; Yunfu Cui; Chaoliu Dai; Chihua Fang; Shuang Feng; Zhili Ji; Weidong Jia; Ningyang Jia; Gong Li; Jing Li; Qiu Li; Jiangtao Li; Tingbo Liang; Lianxin Liu; Shichun Lu; Yi Lv; Yilei Mao; Yan Meng; Zhiqiang Meng; Feng Shen; Jie Shi; Huichuan Sun; Kaishan Tao; Gaojun Teng; Xuying Wan; Tianfu Wen; Liqun Wu; Jinglin Xia; Mingang Ying; Jian Zhai; Leida Zhang; Xuewen Zhang; Zhiwei Zhang; Haiping Zhao; Donghai Zheng; Xuting Zhi; Jie Zhou; Cuncai Zhou; Jian Zhou; Zhaochong Zeng; Kangshun Zhu; Minshan Chen; Jianqiang Cai; Shuqun Cheng
Journal:  Liver Cancer       Date:  2022-03-17       Impact factor: 12.430

5.  [Clinicopathologic analysis of micro and mini parotid gland tumors].

Authors:  B Y Li; Z N Tang; L H Hu; W B Zhang; Y Yu; G Y Yu; X Peng
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-04-18

6.  Evaluation of seven different staging systems for alpha-fetoprotein expression in hepatocellular carcinoma after hepatectomy.

Authors:  Jianguo Zhou; Tao Yan; Xinyu Bi; Hong Zhao; Zhen Huang; Yefan Zhang; Yuan Li; Li Feng; Jing Wang; Jianqiang Cai
Journal:  Tumour Biol       Date:  2013-01-16

7.  Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular Carcinoma.

Authors:  Tom Tan-To Cheung; Philip Chong-Hei Kwok; Stephen Chan; Chin-Cheung Cheung; Ann-Shing Lee; Victor Lee; Hoi-Ching Cheng; Nam-Hung Chia; Charing C N Chong; Tak-Wing Lai; Ada L Y Law; Mai-Yee Luk; Chi Chung Tong; Thomas C C Yau
Journal:  Liver Cancer       Date:  2018-01-25       Impact factor: 11.740

8.  Practice, Knowledge, and Barriers for Screening of Hepatocellular Carcinoma Among High-Risk Chinese Patients.

Authors:  Kerui Xu; Shinobu Watanabe-Galloway; Fedja A Rochling; Jianjun Zhang; Paraskevi A Farazi; Hongyan Peng; Hongmei Wang; Jiangtao Luo
Journal:  Ann Glob Health       Date:  2017-04-19       Impact factor: 2.462

9.  Can Risk Stratification Based on Ultrasound Elastography of Background Liver Assist CEUS LI-RADS in the Diagnosis of HCC?

Authors:  Jiawu Li; Wenwu Ling; Shuang Chen; Lulu Yang; Lin Ma; Qiang Lu; Yan Luo
Journal:  Front Oncol       Date:  2021-04-30       Impact factor: 6.244

10.  Leukocytes infiltration correlates intratumoral microvessel density and influence overall and late-phase disease-free survival in hepatocellular carcinoma.

Authors:  Yuan Yang; Ning Fu; Haiqing Wang; Jingcheng Hao
Journal:  Medicine (Baltimore)       Date:  2021-12-03       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.